收藏切换
Research progress of semaglutide in the treatment of cardiovascular diseases complicated with obesity
收藏切换
Qing MA, Jianqi JIA, Qian HE
World Clinical Drug | 2024, 45(10) : 1099 - 1103
Less
收藏切换
World Clinical Drug | 2024, 45(10): 1099-1103
• Review •
Research progress of semaglutide in the treatment of cardiovascular diseases complicated with obesity
Full
Qing MA, Jianqi JIA, Qian HE
Affiliations
  • Department of Outpatient, the 989th Hospital of the Joint Logistics Support Force of the People's Liberation Army of China, Luoyang 471003, Henan Province, China
Published: 2024-10-10 doi: 10.13683/j.wph.2024.10.016
Outline
收藏切换

Semaglutide was approved by the U.S. Food and Drug Administration on March 8, 2024 for the prevention of cardiovascular disease, heart disease, and cerebral apoplexy in adults who are overweight or obese. Semaglutide improves blood glucose and traditional cardiovascular moderate risk factor levels in obese patients, reduces ectopic adipose tissue that can lead to atherosclerosis and myocardial dysfunction, and improves the systemic pro-inflammatory and pro-thrombotic environment associated with obesity. This article intended to elaborate the mechanism of action, clinical research and safety of semaglutide in the treatment of cardiovascular diseases complicated with obesity from multiple ways and levels, so as to provide certain reference for clinical use.

semaglutide  /  obesity  /  cardiovascular disease
马庆, 贾建旗, 何倩. 司美格鲁肽治疗合并肥胖的心血管疾病研究进展. 世界临床药物, 2024 , 45 (10) : 1099 -1103 . DOI: 10.13683/j.wph.2024.10.016
Qing MA, Jianqi JIA, Qian HE. Research progress of semaglutide in the treatment of cardiovascular diseases complicated with obesity[J]. World Clinical Drug, 2024 , 45 (10) : 1099 -1103 . DOI: 10.13683/j.wph.2024.10.016
Year 2024 volume 45 Issue 10
11
1
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2024.10.016
  • Receive Date:2024-06-14
  • Online Date:2026-11-17
  • Published:2024-10-10
Article Data
Affiliations
History
  • Received:2024-06-14
Affiliations
    Department of Outpatient, the 989th Hospital of the Joint Logistics Support Force of the People's Liberation Army of China, Luoyang 471003, Henan Province, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2024.10.016
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT